[Treatment of brucellosis associated with corynebacterium parvum infection in mice with antibiotics (tetracycline, ampicillin, trimethoprim-sulfamethoxazole)].
D000667:Ampicillin / Q000627:therapeutic use*; D000818:Animals; D002006:Brucellosis / Q000188:drug therapy*; D002452:Cell Count; D003168:Complement Fixation Tests; D003354:Corynebacterium Infections / Q000150:complications*; D004195:Disease Models, Animal; D004338:Drug Combinations; D004347:Drug Interactions; D005069:Evaluation Studies as Topic; D005260:Female; D006386:Hemagglutination Tests; D007274:Injections, Intraperitoneal; D051379:Mice; D009929:Organ Size; D011425:Propionibacterium acnes; D011743:Pyrimidines; D013154:Spleen / Q000187:drug effects / Q000382:microbiology; D013420:Sulfamethoxazole / Q000627:therapeutic use*; D013752:Tetracycline / Q000627:therapeutic use*; D014295:Trimethoprim / Q000627:therapeutic use
D004338:Drug Combinations; D011743:Pyrimidines; D000667:Ampicillin; D014295:Trimethoprim; D013752:Tetracycline; D013420:Sulfamethoxazole
Traitement de la brucellose de la souris par les antibiotiques (tétracycline, ampicilline, triméthoprime-sulfaméthoxazole) en association avec Corynebacterium parvum.